Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

36.15USD
10 Dec 2018
Change (% chg)

$0.67 (+1.89%)
Prev Close
$35.48
Open
$35.41
Day's High
$36.20
Day's Low
$34.96
Volume
1,969,079
Avg. Vol
1,688,265
52-wk High
$39.43
52-wk Low
$24.79

Chart for

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $40,477.75
Shares Outstanding(Mil.): 1,372.13
Dividend: --
Yield (%): --

Financials

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 21 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn (US$4.22bn)bridge loan from Barclays Bank.

21 Nov 2018

Deals of the day-Mergers and acquisitions

Nov 20 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

21 Nov 2018

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 20 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn bridge loan from Barclays Bank.

20 Nov 2018

Boston Scientific builds medical technology with $4.2 billion BTG deal

LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds ($4.24 billion) in cash, adding technology to fight cancer and other serious diseases to its portfolio.

20 Nov 2018

UPDATE 2-Boston Scientific builds medical tech with $4.2 billion BTG deal

* U.S. group's biggest deal since 2006 Guidant acquisition (Adds latest shares, analyst comment, further details)

20 Nov 2018

Boston Scientific offers to buy UK's BTG for about $4.24 billion

Nov 20 U.S. medical device maker Boston Scientific Corp said it offered to buy British pharmaceutical firm BTG Plc for about 3.3 billion pounds ($4.24 billion) in cash.

20 Nov 2018

UPDATE 2-Surgical product sales drive Boston Scientific's profit beat

* Co tightens EPS forecast on foreign exchange headwinds (Adds details from conference call, analyst comment; Updates shares)

24 Oct 2018

Boston Scientific posts 53 percent jump in third-quarter profit

Oct 24 Medical device maker Boston Scientific Corp posted a 52.7 percent jump in quarterly profit on Wednesday, helped by higher sales in its cardiovascular business, which makes stents and heart valves.

24 Oct 2018

Medical device maker Stryker says not in talks to buy Boston Scientific

Medical device maker Stryker Corp is not in talks to buy rival Boston Scientific Corp, the company said in a regulatory filing https://bit.ly/2Jy6VQB on Wednesday, two days after a media report of a potential deal between the two surfaced.

13 Jun 2018

Medical device maker Stryker says not in talks to buy Boston Scientific

Medical device maker Stryker Corp is not in talks to buy rival Boston Scientific Corp , the company said in a regulatory filing https://bit.ly/2Jy6VQB on Wednesday, two days after a media report of a potential deal between the two surfaced.

13 Jun 2018

Earnings vs. Estimates